Fierce Biotech1 min read
saveNovocure denied FDA approval for Optune Mya cancer device after efficacy concerns
Novocure has been hit with a relatively rare “not approvable” letter from the FDA for its tumor-treating electric fields device.
Novocure has been hit with a relatively rare “not approvable” letter from the FDA for its tumor-treating electric fields device.
comments(0)
5-min edit window · permanent after that